Figure 3.
Schematic presentation of the experimental design of the in vivo proof-of-principle study to assess the effect of using the GalNAc-conjugated Stk25 ASO on NAFLD development and progression in obese mice. Cntr, control.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.